Autonomize AI CEO Ganesh Padmanabhan: Running the Business of Care with AI Agents
Healthcare doesn't stall because clinicians lack insight. It stalls in the back and middle office-prior auths, faxes, chart reviews, letters, audits. As CEO Ganesh Padmanabhan puts it: "The bottleneck isn't clinical insight, it's the business of care."
Autonomize AI tackles that work with a HIPAA-compliant, human-in-the-loop platform that uses specialized agents and copilots to organize, structure, and summarize unstructured clinical data. It's built to reduce administrative burden and accelerate decisions across payers, providers, and life sciences.
HIPAA compliance, explainability, and auditability are baked into the approach.
From frustration to focus
Padmanabhan spent two decades shipping AI at scale in other industries. Then a simple question hit him: "If we can optimize ad clicks in milliseconds, why are patients waiting days for care decisions?"
He and co-founder Kris Nair started Autonomize AI to solve that gap. "The true spark wasn't a business plan; it was moral outrage," he said. "We stopped building generic AI and started building specialist agents to fix the business of care."
What the platform actually does
Autonomize doesn't sell a generic platform. It delivers outcomes through pre-built, domain-specific AI Assistants operating on a shared, governed intelligence layer. Think agents that are experts in utilization management, appeals, and care coordination.
The agents take on document-heavy, repetitive tasks with high accuracy-so clinicians and reviewers can focus on decisions and patients, not paperwork.
The Autonomize AI flywheel
- Data Ingestion: Agents ingest and structure unstructured clinical data (notes, faxes, PDFs) with high accuracy.
- Workflow Orchestration: The platform routes outputs to the next logical agent or human, transforming linear processes into AI-native workflows.
- Customer Empowerment: Enterprises leverage a library of agents to compose bespoke workflows across lines of business.
The big shift: from one-off point solutions to an orchestration layer that compounds value across departments and handoffs.
Proof at enterprise scale
Autonomize moved quickly from pilots to production with three of the five largest U.S. health enterprises. That matters-most enterprise GenAI pilots never escape the lab.
Impact metrics include recouping more than 33,000 clinical hours per month, creating over 150,000 automated care plans monthly, and accelerating prior authorization decisions by up to 50%.
One payer cut prior auth review times by over 50% in the first month. "That's 18 minutes of focused time given back to a clinician for every single case," said Padmanabhan.
Trust, explainability, and controls
The main barrier isn't tech-it's trust. "Healthcare leaders have been burned by vaporware," Padmanabhan said. Autonomize's stance: AI must be defensible. Decisions need to be explainable, auditable, and governed with human oversight.
If an organization can't show why an agent took an action, it's not fit for purpose. This is built into the core architecture, not added later.
What sets Autonomize apart
- Healthcare-native: Agents are pre-trained on payer rules, clinical knowledge, and regulatory guardrails.
- System-level orchestration: An intelligence layer that lets multiple agents work in concert across workflows.
- Live at scale: Production deployments across major enterprises with measurable ROI in weeks, not quarters.
As Padmanabhan frames it: most vendors bring a generic hammer. Autonomize brings surgical, domain-specific teammates built for healthcare's messy reality.
For healthcare leaders: a practical evaluation checklist
- Start with a bottleneck: Prior auth, appeals, chart review, care coordination. Define the decision metric that matters.
- Demand auditability: Show why a recommendation was made. Require human-in-the-loop controls.
- Check governance: HIPAA, PHI handling, vendor security posture, data residency, and access controls.
- Prove time-to-value: Target measurable outcomes in 4-8 weeks. Avoid "pilot purgatory."
- Measure human impact: Hours returned to clinicians, time-to-decision, denial reversal rates, and member experience.
- Think beyond a single use case: Can agents be orchestrated across adjacent workflows without new vendor sprawl?
- Plan adoption: Define change management, reviewer workflows, QA thresholds, and escalation paths upfront.
Milestones and momentum
- Funding: $32M raised to date, including a $28M Series A with backing from Cigna Ventures and Valtruis.
- Production scale: Live with three of the five largest U.S. health enterprises.
- Outcomes: 33,000+ clinical hours recouped per month; 150,000+ automated care plans monthly; up to 50% faster prior auth decisions.
What's next
Short term, Autonomize will deepen its marketplace of agents and push closer to the point of care. Long term, the goal is to free human capacity at scale so the system shifts from reactive sick care to proactive care.
"AI should be judged by how it restores trust and accelerates care," said Padmanabhan. "Pair human expertise with defensible automation, and you get faster, fairer decisions."
Want to level up your team's AI capability?
If you're building an AI roadmap for operations or care management, explore role-based programs here: Complete AI Training - Courses by Job.
Your membership also unlocks:
